Meng H. Tan

Researcher Next ID · RN-026260

Researcher · Medicine

Yanji, Peru

Not currently recruitingFunding unknown

Research interests

Medicine

Biochemistry, Genetics and Molecular Biology

Diabetes, Cardiovascular Risks, and Lipoproteins

Diabetes Treatment and Management

Diabetes Management and Research

Metabolism, Diabetes, and Cancer

Lipoproteins and Cardiovascular Health

Obesity in Youth with Type 1 Diabetes in Germany, Austria, and the United States
The Journal of Pediatrics · 2015 · https://doi.org/10.1016/j.jpeds.2015.05.046
Incidence and mechanisms of cardiorespiratory arrests in epilepsy monitoring units (MORTEMUS): a retrospective study
The Lancet Neurology · 2013 · https://doi.org/10.1016/s1474-4422(13)70214-x
Spectrum of Liver Disease in Type 2 Diabetes and Management of Patients With Diabetes and Liver Disease
Diabetes Care · 2007 · 10.2337/dc06-1539
Pioglitazone Use and Heart Failure in Patients With Type 2 Diabetes and Preexisting Cardiovascular Disease
Diabetes Care · 2007 · 10.2337/dc07-0717
Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial
The Lancet · 2005 · https://doi.org/10.1016/s0140-6736(05)67528-9
A Comparison of Lipid and Glycemic Effects of Pioglitazone and Rosiglitazone in Patients With Type 2 Diabetes and Dyslipidemia
Diabetes Care · 2005 · https://doi.org/10.2337/diacare.28.7.1547
Pioglitazone Reduces Atherogenic Index of Plasma in Patients with Type 2 Diabetes
Clinical Chemistry · 2004 · 10.1373/clinchem.2004.031757
Increased Lipoprotein-Remnant Formation in Chronic Renal Failure
New England Journal of Medicine · 1982 · 10.1056/nejm198208053070601

No projects listed.